To assess associations of a commercially available carboxymethylcellulose adhesion barrier placed during primary cesarean delivery with clinical outcomes of repeat cesarean deliveries.
OBJECTIVE:
To assess associations of a commercially available carboxymethylcellulose adhesion barrier placed during primary cesarean delivery with clinical outcomes of repeat cesarean deliveries.
METHODS:
We performed a retrospective cohort study of women undergoing primary cesarean delivery on or after January 1, 2008, and first repeat cesarean delivery in one of four hospitals in the same system by June 30, 2011. Women were included if both deliveries were live singletons at 34-42 weeks of gestation delivered through transverse abdominal incisions and the first hysterotomy was low transverse. Exclusion criteria included intervening delivery; puerperal infection, bowel injury, or bladder injury at primary cesarean delivery; uterine incision or laparotomy (except primary cesarean delivery) before repeat cesarean delivery; and use of another adhesion barrier at primary cesarean delivery. As a surrogate for adhesion grading, the primary outcome was time from skin incision to neonate delivery at repeat cesarean delivery. We also assessed total operative time and rates of selected surgical complications.
RESULTS: There were 517 women who met criteria; 248 received the adhesion barrier during primary cesarean delivery and 269 did not. There were no demographic differences between groups except delivery hospital. In the adhesion barrier and no adhesion barrier groups, respectively, mean6standard deviation times to delivery at repeat cesarean delivery were 6.163.0 compared with 5.862.5 minutes (P5.25), and total operative times were 31.2610.6 compared with 31.8611.6 minutes (P5.56). Surgical complications were not different between groups.
CONCLUSION: Placing a commercially available carboxymethylcellulose adhesion barrier at primary cesarean delivery is not associated with decreased time to delivery, total operative time, or complications during repeat cesarean deliveries. 
LEVEL OF EVIDENCE: II
T he cesarean delivery rate in the United States rose from 5% in 1970 to 33% in 2010, and approximately 90% of women with a prior cesarean currently have a repeat cesarean delivery in their next pregnancy.
1,2 The 2010 U.S. cesarean delivery rate represents almost a 60% increase since 1996. [1] [2] [3] Of the 4 million births in the United States annually, more than 1.3 million are performed through cesarean delivery. Adhesions that occur as a result of a prior cesarean delivery have been implicated as one cause of delayed delivery of the neonate during repeat cesarean deliveries. 4 It is assumed that such a delay from skin incision to delivery of the neonate will affect some newborns negatively, particularly in situations in which the cesarean delivery is being undertaken as a result of one or more urgent or emergent indications. 5 In addition, it is reasoned that such adhesions may increase the likelihood of maternal complications such as blood loss and injury to viscera. Seprafilm (sodium hyaluronate and carboxymethylcellulose absorbable adhesion barrier) is a commercially available product that is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct that is intended to reduce the incidence, extent, and severity of adhesion formation between the abdominal wall and the intraabdominal viscera (Seprafilm package insert). However, data regarding use of this product for adhesion prevention at the time of cesarean delivery are limited to a single study of 52 patients. 7 That study reported that, at the time of repeat cesarean delivery, the group receiving the carboxymethylcellulose adhesion barrier had a significantly shorter mean time from skin incision to delivery of the neonate, a shorter mean time from skin incision to completion of the cesarean delivery, and fewer adhesions (7.4% compared with 48%; P5.001). However, the study was limited by its small size, lack of randomization, and lack of blinding to group assignment.
The ideal study design to evaluate the association between use of the carboxymethylcellulose adhesion barrier at primary cesarean delivery and outcomes at repeat cesarean delivery would be a randomized controlled trial in which one group of patients had the barrier placed at primary cesarean delivery and adhesions, operative injuries, and maternal and perinatal outcomes were assessed at the time of repeat cesarean delivery in the next pregnancy. There are three such trials currently registered on clinicaltrials.gov (as of November 14, 2013). [8] [9] [10] One of these trials has not yet begun enrolling patients. Both of the other two trials, presumably as a result of funding issues, have terminated enrollment before reaching half of the target sample size. The next best level of evidence besides a randomized controlled trial is provided by one or more well-designed cohort studies. The objective of the current cohort study was to assess the associations between placement of the carboxymethylcellulose adhesion barrier during primary cesarean deliveries with surgical and clinical outcomes of repeat cesarean deliveries.
MATERIALS AND METHODS
We conducted a retrospective cohort study of all women undergoing primary cesarean delivery on or after January 1, 2008, and first repeat cesarean delivery in one of four hospitals in the Banner Health System by June 30, 2011. These four hospitals all are in the Phoenix, Arizona, metropolitan area and include Banner Estrella Medical Center (Glendale, Arizona), Banner Thunderbird Medical Center (Glendale, Arizona), Banner Desert Medical Center (Mesa, Arizona), and Banner Gateway Medical Center (Gilbert, Arizona). Resident physicians do not participate in deliveries at these four hospitals. The institutional review board of Banner Good Samaritan Medical Center (Phoenix, Arizona) approved the study.
Electronic medical records were reviewed no sooner than 6 months after the repeat cesarean delivery. Potentially eligible patients were identified by a query of the Banner Health System billing database. Individual patient electronic medical records then were reviewed by trained research personnel (M.I., A.V.B.-B., and others). Data abstraction was validated by secondary review of a subset of the data collection forms. Additional inclusion criteria included: both deliveries were live singleton neonates at 34-42 weeks of gestation, delivered through transverse abdominal incisions, and the first hysterotomy was low transverse. Exclusion criteria included: having an intervening delivery; immune dysfunction (eg, human immunodeficiency virus infection); puerperal infection, bowel injury, or bladder injury at the time of primary cesarean delivery; pelvic inflammatory disease, uterine incision (eg, myomectomy), or laparotomy (except the primary cesarean) before the repeat cesarean delivery; systemic steroids (except for fetal benefit) within 6 months before either cesarean delivery; and use of another adhesion barrier at the time of primary cesarean delivery. In these hospitals, there was no protocol related to use of adhesion barriers at the time of cesarean delivery, and use or nonuse of the adhesion barrier was not part of a study. Use or nonuse of the carboxymethylcellulose adhesion barrier was per the discretion of the managing physician.
As a surrogate for adhesion grading, the primary outcome variable was time from skin incision to neonate delivery at repeat cesarean delivery. Others have used this outcome variable and shown that it is associated both with increasing maternal body mass index (BMI, calculated as weight (kg)/[height (m)] 2 ) and with neonatal morbidity. 11 Secondary outcomes included total operative time during repeat cesarean delivery, estimated blood loss, rates of complications related to the repeat cesarean delivery (estimated blood loss, endometritis, wound abscess, wound cellulitis, pelvic abscess, urinary infection, hospital readmission, and reoperation), and immediate neonatal complications (eg, 5-minute Apgar score less than 7). If noted in the operative report, adhesion descriptions were recorded.
Abstracted data were entered into a computerized spreadsheet. Data management and analyses were performed using SPSS 21.0. Continuous variables were analyzed using the unpaired Student's t test. Categorical variables were analyzed using x 2 or Fisher's exact test, as appropriate. Linear regression was used to evaluate factors affecting the incision to delivery time at repeat cesarean delivery. Logistic regression was used to evaluate for independent predictors of adhesions at repeat cesarean delivery. A priori, we estimated needing 420 patients to detect a 2.0-minute difference in the primary outcome variable with a standard deviation of 5.0 minutes. This sample size calculation assumed a 2:1 ratio of nonuse to use of the carboxymethylcellulose adhesion barrier with a50.01 and b50.1.
RESULTS
There were 517 women who met criteria and were included in the analysis; 248 received the carboxymethylcellulose adhesion barrier during the primary cesarean delivery and 269 did not. See Figure 1 for a flow diagram showing details of patients excluded to arrive at the analyzed sample size.
At the time of primary cesarean delivery, there were no demographic differences between groups except for delivery hospital (Table 1) . Table 2 shows clinical outcomes at the time of the primary cesarean delivery; the group that had the carboxymethylcellulose adhesion barrier placed had significantly longer mean total operative times, more often had their skin closed with staples, and had higher mean estimated blood loss. One patient in each group required use of exogenous thrombin application. There were 109 different physicians who performed these primary cesarean deliveries.
Demographic data at the time of repeat cesarean delivery are shown in Table 3 . There were no significant differences between groups. Less than 10% of patients in either group were in labor at the time of the repeat cesarean delivery. Table 4 shows clinical outcomes at the time of the repeat cesarean delivery. The primary outcome variable (time from skin incision to neonate delivery) was no different between groups. Those patients who had the carboxymethylcellulose adhesion barrier placed at the time of the primary cesarean delivery were more likely to have their skin closed with staples compared with suture at the time of repeat cesarean delivery and had a greater mean estimated blood loss at repeat cesarean delivery. No other perioperative outcomes at the time of repeat cesarean delivery were different between groups. Four patients in each group required the use of exogenous thrombin application. Only one patient had a uterine incision at the time of repeat cesarean delivery that was not low transverse; she was in the group that received the carboxymethylcellulose adhesion barrier during the primary cesarean delivery. There was one patient in each group who had a bladder injury at the time of repeat cesarean delivery (P5.96). There were no bowel injuries or cases of chorioamnionitis. There were 114 different physicians who performed these repeat cesarean deliveries.
Postoperative complications also are shown in Table 4 . There were no significant differences between groups. However, we were underpowered to evaluate rare outcomes. There were numerically more patients readmitted to the hospital in the group who received the carboxymethylcellulose adhesion barrier at the time of the primary cesarean delivery (five patients compared to none in the other group; P5.02). Of these patients requiring readmission, two had pelvic abscesses, one of which required repeat laparotomy for drainage, two were readmitted as a result of hypertension, and one had pneumonia.
Using linear regression, the only independent significant predictor affecting the incision to delivery time at repeat cesarean delivery was the incision to delivery time at primary cesarean delivery (P,.001); for each extra minute of incision to delivery time at primary cesarean delivery, approximately 16 (95% confidence interval [CI] 10-22) seconds were added to the incision to delivery time at repeat cesarean delivery (b50.27). The following variables relating to the first cesarean delivery were evaluated using logistic regression: BMI, use of the adhesion barrier, incision to delivery, total operative time, estimated blood loss, and skin closure technique. All six of those potential predictors then were entered in a multiple regression, the resultant model of which is shown in Table 5 . To determine which predictor(s) would stay in the final model, all six of these potential predictors were entered using both backward and forward logis- Data are mean6standard deviation or n (%) unless otherwise specified. * Maximum temperature during the entire postpartum hospital stay. BMI, body mass index. Data are mean6standard deviation, range, or n (%) unless otherwise specified.
tic regression methods with only those variable(s) significant at P,.05 being retained. The final model included only BMI as a significant predictor; for each additional unit of BMI, the risk of adhesions at repeat cesarean delivery increased 6% (odds ratio 1.06, 95% CI 1.02-1.10).
DISCUSSION
The data from this study demonstrate that placing a carboxymethylcellulose adhesion barrier at primary cesarean delivery is not associated with a decrease in time to neonate delivery during repeat cesarean deliveries. As a result of the retrospective nature of this study, we chose this variable as our primary outcome as a surrogate for adhesion grading. In the linear regression analysis, the only significant predictor of time to neonate delivery at repeat cesarean delivery was time to neonate delivery during the primary cesarean delivery. Patient characteristics such as BMI likely explain that association. Despite the difficulty of assessing adhesion quality in a retrospective study, we did evaluate the description of adhesions if included in the operative report. Like time to neonate delivery, use of the carboxymethylcellulose barrier was not associated with any improvement in the prevalence of either adhesions in general or more significant adhesions (moderate, dense, or fibrovascular). We did not anticipate finding an association between obesity and adhesions at the time of repeat cesarean delivery. Perhaps this association is the result of increased operative time and tissue handling in such patients or the result of obesity being a proinflammatory state.
Like all such analyses, our study is limited by its retrospective nature and the limitations inherent in such a design. Although we observed no attrition of patients, we could have underestimated the rates of postpartum complications, because some patients might have sought care for such complications at facilities outside this hospital system. In fact, the rates of some of these postpartum complications were lower than anticipated. Furthermore, we used a surrogate primary outcome variable. Finally, we were not able to control for differences in surgical technique; as an example, we could not assess for whether certain sites or certain physicians were more or less likely to use sharp or blunt dissection.
However, there are several strengths of our study. We had a large sample size of women undergoing successive cesarean deliveries in the same hospital system. The enrollment criteria were designed to minimize the effect of extraneous factors such as other operations or intervening deliveries on the outcomes, and we performed regression analyses to control for differences between groups. Also, the fact that the deliveries were performed by more than 100 Data are mean6standard deviation or n (%) unless otherwise specified. * Only one patient in the entire cohort had an estimated blood loss in excess of 1,000 mL. She was in the "use" group and had an estimated blood loss of 2,000 mL. We did not collect data regarding number of patients who had blood transfusions. † Maximum temperature during the entire postpartum hospital stay. obstetricians in practice makes these data generalizable to many practice settings. In addition to there being no association with time to neonate delivery at repeat cesarean delivery, use of the carboxymethylcellulose adhesion barrier at the time of primary cesarean delivery was not associated with a decrease in total operative time for repeat cesarean delivery or rates of operative complications related to repeat cesarean delivery. In fact, we were unable to demonstrate any advantage to placement of the carboxymethylcellulose adhesion barrier at the time of primary cesarean delivery.
In the absence of any data supporting improved outcomes with repeat cesarean deliveries, we think that the carboxymethylcellulose adhesion barrier should not be used during cesarean deliveries. The product is expensive; an estimate from a study evaluating the cost-effectiveness of this product for use during radical hysterectomy was $493 (U.S. dollars in 2006), 12 and this amount is less than a recent estimate from our hospital purchasing officer. At that price, using the product during every cesarean delivery would cost approximately two-thirds of a billion dollars annually in the United States alone. Certainly, such a cost can only be justified if there is clear benefit. Until such a benefit is demonstrated in a well-designed randomized controlled trial, we think that there is no role for using the carboxymethylcellulose adhesion barrier during cesarean deliveries.
